Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Eye cancer refers to malignant tumors occurring in the eyeball or its accessory structures, mainly including ocular melanoma and retinoblastoma. The disease can originate primarily in the eye or metastasize from other cancers. Due to the delicate structure of eye tissues, once malignancy occurs, it not only affects vision but may also spread to the brain and throughout the body, posing serious risks to life. The affected population spans widely, from infants to the elderly, requiring high attention.
Eye cancer is relatively rare worldwide, but its occurrence is related to race and region. For example, ocular melanoma is more common in Caucasian populations but rare in Asians; retinoblastoma in children has a lower early detection rate in developing countries, affecting treatment opportunities.
1. Visual impairment
The most direct harm of eye cancer is impaired vision. Tumors may compress the retina, obstruct light transmission, and cause blurred vision, visual field loss, or even blindness. For children with bilateral disease, learning and quality of life are also impacted.
2. Structural damage to the eyeball
As the tumor grows, the eyeball structure may be destroyed, resulting in deformation, protrusion, or even rupture, affecting appearance and causing secondary infections, bringing both physical and psychological trauma.
3. Intracranial and systemic metastasis
Certain types of eye cancer, such as malignant melanoma and retinoblastoma, may spread through blood or neural pathways to the brain or other organs, increasing treatment difficulty and mortality.
4. Psychological and social stress
Eye cancer not only causes physical suffering but also appearance changes and vision loss, often leading to anxiety, depression, and inferiority, affecting social and family relationships, requiring comprehensive intervention.
Immune reconstruction cell therapy activates and reconstructs the patient’s immune system, improving its ability to recognize and eliminate tumor cells. It is particularly suitable for eye cancer patients who are resistant to radiotherapy and chemotherapy or have relapsed. This therapy emphasizes a triple mechanism of "recognition-attack-reconstruction," not only fighting tumors but also helping repair immune structures damaged during treatment, making it a precise therapeutic approach gaining increasing attention in recent years.
In practice, patients undergoing traditional therapies such as surgery, radiotherapy, and chemotherapy often face immune dysfunction, increased risk of infection, and slow recovery. To better support patients through treatment, improve tolerance, and enhance quality of life, phased immune reconstruction plans tailored to different treatment cycles should be scientifically developed.
● Short-term plan: Rapidly enhance immunity through immune cell reinfusion, boosting the effectiveness of anti-tumor treatment.
● Mid-term plan: Reduce side effects of traditional treatments, promote physical recovery, and complete standardized treatment courses.
● Long-term plan: Improve overall immunity through immune cell reconstruction, gut immune reconstruction, elemental immune reconstruction, and immune nutrition reconstruction, thereby enhancing quality of life and prolonging survival.
1. Radiotherapy
Radiotherapy is a common treatment for eye cancers, especially melanoma, using gamma knife, proton beam, or eye-adapted gamma irradiation to precisely target local tumors while protecting surrounding tissues. It is suitable for early or mid-stage patients and has the advantages of minimal trauma and quick recovery.
2. Local excision and enucleation
When the tumor is relatively localized, local excision may be performed to preserve the eyeball. However, if the disease progresses severely, enucleation may be required to prevent tumor spread, after which artificial eyes can be fitted to restore appearance and reduce psychological impact.
3. Targeted drug therapy
For certain eye cancer types with specific genetic mutations, such as some ocular melanomas, targeted drugs may block tumor signaling pathways. This therapy has relatively mild side effects and is suitable for long-term maintenance or postoperative recurrence prevention.
4. Minimally invasive laser therapy
For early retinoblastoma, laser-based thermotherapy or cryotherapy can treat lesions with minimal damage and rapid recovery. It is often combined with other therapies, especially for children, helping preserve vision and delaying enucleation.
5. Chemotherapy and intra-arterial infusion therapy
Chemotherapy remains important in treating retinoblastoma and other eye cancers. Recently, intra-arterial chemotherapy delivers drugs directly into the tumor’s blood supply artery via catheter, reducing systemic side effects while increasing local efficacy and control rates.
Eye cancer, as a serious malignant disease, requires early detection and scientific treatment. Experts at United Life International Medical Center emphasize that integrating multidisciplinary resources and advanced methods such as immune reconstruction cell therapy offers patients the potential for longer survival and better recovery outcomes.
